Middle East Cancer Pain Management market is projected to grow from $260.8 Mn in 2022 to $425.18 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The main factors driving the growth would be the rise in cancer incidence, technological advancements in pain relief, and the expansion of the healthcare industry. The market is segmented by drug type and by disease. Some of the major players include NewBridge Pharmaceuticals, Neopharma, Abbott, Pfizer, Johnson & Johnson, and Sanofi.
Middle East Cancer Pain Management market is projected to grow from $260.8 Mn in 2022 to $425.18 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The GDP and healthcare spending of countries in the Middle East vary substantially. Qatar and the United Arab Emirates are two Middle Eastern countries with high GDPs and significant healthcare expenditures. Others with smaller GDPs and lower healthcare spending include Yemen and Syria.
The majority of chronic pain is brought on by cancer, while the majority of acute pain is brought on by therapy or diagnostic procedures related to cancer. Uncomfortable side effects from chemotherapy and radiotherapy may persist for a long time following the course of treatment. The location and stage of the tumor have the most effects on whether or not there is discomfort. Patients with malignant cancer have pain constantly, and two-thirds of those with advanced illness experience it to the point that it interferes with their sleep, emotions, social interactions, and daily activities.
The Middle East has the greatest and lowest rates of cancer, with Egypt and Lebanon reporting 159.4 and 165.8 cases per 100,000 persons, respectively, and Saudi Arabia and Sudan reporting 96.4 and 95.7 cases, respectively.
Market Growth Drivers
The Middle East cancer pain management market is fueled by a number of reasons, including the rise in cancer incidence, technological advancements in pain relief, and the expansion of the healthcare industry. The prevalence of cancer is increasing in the Middle East, and lifestyle-related malignancies like breast, lung, and colorectal cancers are becoming more common. Cancer pain management services and therapies are in high demand as a result of the rise in cancer diagnoses. Furthermore, improvements in pain management technologies and therapies are enhancing the efficacy of pain management for cancer patients and producing more favorable results.
Market Restraints
The Middle East cancer pain management market is constrained by a number of issues, including poor insurance coverage, a lack of healthcare resources, and high pricing for treatments and services. Patients may find it challenging to receive these services due to the Middle East's limited supply of pain management services, particularly in rural and outlying areas. Additionally, there are differences in the Middle East regarding insurance coverage for cancer pain management services, with some nations providing complete coverage while others do not. Patients in nations with limited insurance coverage or payment rules may have fewer access options for pain treatment services as a result.
Key Players
December 2022: Sanofi and Innate Pharma announced the expansion of their collaboration with the licensing of an NK cell engager program from Innate's ANKETTM (Antibody-based NK Cell Engager Therapeutics) technology that targets B7H3. Sanofi will also have the option of adding up to two more ANKETTM targets. Following candidate selection, Sanofi will be in charge of all development, manufacturing, and marketing.
Governmental policies and healthcare laws have an impact on the Middle East cancer pain management market's regulatory environment. The introduction of new pain management medications and treatments is delayed by the region's normally strict and stretched drug approval process.
In UAE, the Ministry of Health and Prevention (MOH), the primary healthcare regulatory authority, is in charge of drafting the rules and policies governing the management of cancer pain. According to the MOH, all medical facilities, including those providing cancer pain management therapies, must have the proper licenses and registrations.
In Saudi Arabia, the Saudi Food and Drug Authority (SFDA) and the Ministry of Health (MOH) are primarily in charge of governing healthcare regulations and the management of cancer pain. The MOH sets standards and guidelines for the provision of medical services, including the management of pain in cancer patients. Drugs used to manage pain must be supervised and approved by the SFDA.
The Middle East cancer pain management market's reimbursement landscape is complicated and differs from nation to nation. For instance, there is extensive insurance coverage for cancer treatments and pain management services in nations like the UAE and Saudi Arabia, including reimbursement for prescription medications, medical procedures, and other related charges. On the other hand, patients may have to pay a sizeable percentage of the cost of cancer pain management therapies out-of-pocket in nations like Yemen and Iraq where insurance coverage is scarce.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Drug Type (Revenue, USD Billion):
Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.
By Disease Indication (Revenue, USD Billion):
Based on disease Indication the market is segmented into:
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?